Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Natali Pflug, Geothy Chakupurakal, Anna-Maria Fink, Sandra Robrecht, Marco Herling, Paula Cramer, Udo Holtick, Sebastian Theurich, Johannes Schetelig, Kirsten Fischer, Matthias Ritgen, Christof Scheid, Barbara Eichhorst, Peter Dreger, Michael Hallek, Michael von Bergwelt-Baildon, on behalf of the German CLL Study Group
Format: article
Langue:EN
Publié: Wolters Kluwer 2021
Sujets:
Diseases of the blood and blood-forming organs
RC633-647.5
Accès en ligne:https://doaj.org/article/2bb4b1c0048143b29f0e46696ee44349
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/2bb4b1c0048143b29f0e46696ee44349

Documents similaires